Exelixis remains dedicated to serving your needs and those of your patients. While the conference is assuming a virtual format this year, our commitment to patient care has not changed. Our team will continue to provide support to you and your patients in these challenging times. To ensure you have the latest clinical data, including links to our pivotal trial publications, and important information about the support materials below, visit our website.
Full Prescribing Information »
CABOMETYX® (cabozantinib) Resources »
Exelixis Access Services® (EASE) »
Talk Face to Face with Exelixis »
Meeting ID: 271 406 7602
Passcode: 6zw3Ng
